Verition Fund Management
TMO icon

Verition Fund Management’s Thermo Fisher Scientific TMO Stock Holding History

Verition Fund Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-12,500
Closed -$6.06M – 3947
2025
Q3 		$6.06M Sell
12,500
-2,300
-16% -$1.07M 0.03% 941
2025
Q2 		$6M Buy
14,800
+2,800
+23% +$1.17M 0.03% 940
2025
Q1 		$5.97M Buy
12,000
+6,000
+100% +$3.25M 0.03% 725
2024
Q4 		$3.12M Sell
6,000
-1,900
-24% -$1.04M 0.01% 1239
2024
Q3 		$4.89M Sell
7,900
-2,100
-21% -$1.24M 0.02% 866
2024
Q2 		$5.53M Buy
10,000
+6,300
+170% +$3.61M 0.03% 671
2024
Q1 		$2.15M Buy
3,700
+2,900
+363% +$1.63M 0.01% 1168
2023
Q4 		$425K Hold
800
– – ﹤0.01% 1597
2023
Q3 		$405K Buy
800
+200
+33% +$107K ﹤0.01% 1555
2023
Q2 		$313K Buy
600
+200
+50% +$108K ﹤0.01% 1531
2023
Q1 		$231K Buy
+400
New +$225K ﹤0.01% 1679
2022
Q2 		– Sell
-2,300
Closed -$1.36M – 3030
2022
Q1 		$1.36M Buy
2,300
+2,000
+667% +$1.15M 0.02% 1263
2021
Q4 		$200K Buy
+300
New +$187K ﹤0.01% 2247

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Verition Fund Management's TMO Position: Q1 2026 in Review

Verition Fund Management increased its Thermo Fisher Scientific (TMO) stake by 24% in Q1 2026, buying an estimated $2.22M and bringing the position to 21,462 shares worth $10.5M. The position accounts for 0.07% of the portfolio, ranked #307.

Verition Fund Management first reported a position in TMO in Q2 2013 and has held it in 29 quarters since. The position peaked at $16.7M in Q1 2025. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Verition Fund Management held 21,462 shares of Thermo Fisher Scientific worth $10.5M as of Q1 2026.
  • Verition Fund Management bought 4,099 Thermo Fisher Scientific shares in Q1 2026, an estimated $2.22M.
  • Thermo Fisher Scientific made up 0.07% of Verition Fund Management's portfolio in Q1 2026, its #307 holding.
  • Verition Fund Management first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 29 quarters since.
  • Verition Fund Management's Thermo Fisher Scientific position peaked at $16.7M in Q1 2025.
  • 2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.